Article
Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer.
Cells - 25 Jan 2022
Eltayeb Kamal, La Monica Silvia, Tiseo Marcello, Alfieri Roberta, Fumarola Claudia
Abstract excerpt
Lung cancer is the leading cause of cancer deaths worldwide. Most of lung cancer cases are classified as non-small cell lung cancers (NSCLC). EGFR has become an important therapeutic target for the treatment of NSCLC patients, and inhibitors targeting the kinase domain of EGFR are currently used in clinical settings. Recently, an increasing interest has emerged toward understanding the mechanisms and biological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.